Surachet Imlimthan

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

Molecular pharmaceutics

Molecules (Basel, Switzerland)

Bioconjugate chemistry

Biomacromolecules

Siam Quality Starch Co., Ltd.

The University of Helsinki (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Siam Quality Starch Co., Ltd.

Thailand

Technical engineer :: Research and development

Education History

The University of Helsinki Dec 01 2016

Finland

PHD :: Department of Chemistry

The University of Tokyo Apr 01 2014 - Mar 31 2016

Japan

MSC :: Bioengineering

King's Mongkut University of Technology Thonburi May 15 2005 - Apr 02 2008

Thailand

BSC :: Chemical Engineering

Publications

Tilman Läppchen, Adrianna Bilinska, Eirinaios Pilatis, Elena Menéndez, Surachet Imlimthan, Euy Sung Moon, Ali Afshar-Oromieh, Frank Rösch, Axel Rominger, Eleni Gourni
Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68 Ga- and 177 Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi) 2 . Molecules (Basel, Switzerland) 29 (13) (2024)
Tilman Läppchen, Adrianna Bilinska, Eirinaios Pilatis, Elena Menéndez, Surachet Imlimthan, Euy Sung Moon, Ali Afshar-Oromieh, Frank Rösch, Axel Rominger, Eleni Gourni
Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68 Ga- and 177 Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi) 2 . Molecules (Basel, Switzerland) 29 (13) (2024)
Tilman Läppchen, Adrianna Bilinska, Eirinaios Pilatis, Elena Menéndez, Surachet Imlimthan, Euy Sung Moon, Ali Afshar-Oromieh, Frank Rösch, Axel Rominger, Eleni Gourni
Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68 Ga- and 177 Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi) 2 . Molecules (Basel, Switzerland) 29 (13) (2024)
Sofia Otaru, Andreas Paulus, Surachet Imlimthan, Iida Kuurne, Helena Virtanen, Heidi Liljenbäck, Tuula Tolvanen, Tatsiana Auchynnikava, Anne Roivainen, Kerttuli Helariutta, Mirkka P Sarparanta, Anu J Airaksinen
Development of [ 18 F]AmBF 3 Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [ 18 F]AmBF 3 -PEG 7 -Tyr 3 -Octreotide in an AR42J Pancreatic Carcinoma Model. Bioconjugate chemistry 33 (7) (2022)
Jelena Matović, Juulia Järvinen, Iris K Sokka, Philipp Stockmann, Martin Kellert, Surachet Imlimthan, Mirkka P Sarparanta, Mikael P Johansson, Evamarie Hey-Hawkins, Jarkko Rautio, Filip S Ekholm
Synthesis and In Vitro Evaluation of a Set of 6-Deoxy-6-thio-carboranyl d-Glucoconjugates Shed Light on the Substrate Specificity of the GLUT1 Transporter. ACS omega 7 (34) (2022)
Dave Lumen, Danielle J Vugts, Marion Chomet, Surachet Imlimthan, Mirkka P Sarparanta, Ricardo Vos, Maxime Schreurs, Mariska Verlaan, Pauline A Lang, Eero Hippeläinen, Wissam Beaino, Albert D Windhorst, Anu J Airaksinen
Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [ 89 Zr]Zr-DFO-PEG 5 -Tz. Bioconjugate chemistry 33 (5) (2022)
Elisavet Lambidis, Chun-Chieh Chen, Mo Baikoghli, Surachet Imlimthan, You Cheng Khng, Mirkka P Sarparanta, R Holland Cheng, Anu J Airaksinen
Development of 68 Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET. Molecular pharmaceutics 19 (8) (2022)
Surachet Imlimthan, Euy Sung Moon, Hendrik Rathke, Ali Afshar-Oromieh, Frank Rösch, Axel Rominger, Eleni Gourni
New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Surachet Imlimthan, You Cheng Khng, Outi M Keinänen, Wenzhong Zhang, Anu J Airaksinen, Mauri A Kostiainen, Brian M Zeglis, Hélder Almeida Santos, Mirkka P Sarparanta
A Theranostic Cellulose Nanocrystal-Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma. Small (Weinheim an der Bergstrasse, Germany) 17 (18) (2021)
Iris K Sokka, Surachet Imlimthan, Mirkka P Sarparanta, Hannu Maaheimo, Mikael P Johansson, Filip S Ekholm
Halogenation at the Phenylalanine Residue of Monomethyl Auristatin F Leads to a Favorable cis/trans Equilibrium and Retained Cytotoxicity. Molecular pharmaceutics 18 (8) (2021)
Jelena Matović, Juulia Järvinen, Iris K Sokka, Surachet Imlimthan, Jan-Erik Raitanen, Ahmed B Montaser, Hannu Maaheimo, Kristiina M Huttunen, Sirpa Peräniemi, Anu J Airaksinen, Mirkka P Sarparanta, Mikael P Johansson, Jarkko Rautio, Filip S Ekholm
Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and In Vitro Evaluation of the Entire Positional Isomer Library of ortho-Carboranylmethyl-Bearing Glucoconjugates. Molecular pharmaceutics 18 (1) (2020)
Jelena Matović, Juulia Järvinen, Helena C Bland, Iris K Sokka, Surachet Imlimthan, Ruth Mateu Ferrando, Kristiina M Huttunen, Juri M Timonen, Sirpa Peräniemi, Olli Aitio, Anu J Airaksinen, Mirkka P Sarparanta, Mikael P Johansson, Jarkko Rautio, Filip S Ekholm
Addressing the Biochemical Foundations of a Glucose-Based "Trojan Horse"-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to In Vitro Assessment. Molecular pharmaceutics 17 (10) (2020)
Sofia Otaru, Surachet Imlimthan, Mirkka P Sarparanta, Kerttuli Helariutta, Kristiina Wähälä, Anu J Airaksinen
Evaluation of Organo [18F]Fluorosilicon Tetrazine as a Prosthetic Group for the Synthesis of PET Radiotracers. Molecules (Basel, Switzerland) 25 (5) (2020)
Dave Lumen, Simo Näkki, Surachet Imlimthan, Elisavet Lambidis, Mirkka P Sarparanta, Wujun Xu, Vesa-Pekka Lehto, Anu J Airaksinen
Site-Specific 111In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model. Pharmaceutics 11 (12) (2019)
Surachet Imlimthan, Alexandra Correia, Patrícia Figueiredo, Kalle Lintinen, Vimalkumar Balasubramanian, Anu J Airaksinen, Mauri A Kostiainen, Hélder Almeida Santos, Mirkka P Sarparanta
Systematic in vitro biocompatibility studies of multimodal cellulose nanocrystal and lignin nanoparticles. Journal of biomedical materials research. Part A 108 (3) (2019)
Surachet Imlimthan, Sofia Otaru, Outi Keinänen, Alexandra Correia, Kalle Lintinen, Hélder Almeida Santos, Anu J Airaksinen, Mauri A Kostiainen, Mirkka P Sarparanta
Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications. Biomacromolecules 20 (2) (2018)

Surachet Imlimthan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Surachet Imlimthan